Show simple item record

dc.contributor.authorMehta, P.en
dc.contributor.authorAl-Kinani, Ali A.en
dc.contributor.authorArshad, Muhammad Sohailen
dc.contributor.authorSingh, Neenuen
dc.contributor.authorvan der Merwe, Susanna M.en
dc.contributor.authorChang, Ming-Weien
dc.contributor.authorAlany, Raid G.en
dc.contributor.authorAhmad, Z.en
dc.date.accessioned2018-11-08T11:28:21Z
dc.date.available2018-11-08T11:28:21Z
dc.date.issued2018-12-01
dc.identifier.citationMehta, P. et al. (2018) Engineering and development of chitosan-based Nanocoatings for Ocular Contact Lenses. Journal of Pharmaceutical Sciences, 108 (4), pp. 1540-1551en
dc.identifier.urihttp://hdl.handle.net/2086/17117
dc.descriptionThe file attached to this record is the author's final peer reviewed version. The Publisher's final version can be found by following the DOI link.en
dc.description.abstractThe research manuscript reports on Electrohydrodynamic Atomisation (EHDA) to engineer on-demand novel coatings for ocular contact lenses. A formulation approach was adopted to modulate the release of timolol maleate (TM) using chitosan and borneol. Polymers polyvinylpyrrolidone (PVP) and poly (N-isopropylacrylamide) (PNIPAM) were utilised to encapsulate TM and were electrically atomised to produce optimised, stationary contact lens coatings. The particle and fibre diameter, thermal stability, material compatibility of the formed coatings along with their in vitro release-modulating effect and ocular tolerability were investigated. The results demonstrated highly stable nano-matrices with advantageous morphology and size. All formulations yielded coatings with high TM encapsulation (>88%); with excellent ocular biocompatibility. The coatings presented biphasic and triphasic release profiles; depending on composition. Kinetic modelling revealed a noticeable effect of chitosan; the higher the concentration, the more the release of TM due to chitosan swelling; with the release mechanism changing from Fickian diffusion (1% w/v; n = 0.5) to non-Fickian (5% w/v, 0.45 < n < 0.89). The use of EHDA has not yet been explored in depth within the ocular research remit; engineering on demand lens coatings capable of sustaining TM release. This is likely to offer an alternative dosage form for management of glaucoma with particular emphasis on improving poor patient compliance.en
dc.language.isoenen
dc.titleEngineering and development of chitosan-based Nanocoatings for Ocular Contact Lensesen
dc.typeArticleen
dc.identifier.doihttps://dx.doi.org/10.1016/j.xphs.2018.11.036
dc.researchgroupPharmaceutical Technologiesen
dc.peerreviewedYesen
dc.funderN/Aen
dc.projectidN/Aen
dc.cclicenceCC-BY-NCen
dc.date.acceptance2018-11-03en
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record